Xiao Ding

4.6k citations
118 papers · 2.7k indexed · 1 hit paper · h-index 28
Topics
Bioactive Natural Diterpenoids Research (14 papers)HIV/AIDS drug development and treatment (13 papers)HIV Research and Treatment (11 papers)

In The Last Decade

Xiao Ding

114 papers receiving 2.7k citations

Hit Papers

Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 si...20212026202220242021100200300

Peers

Xiao Ding
Comparison fields: 5 of 134
  • Molecular Biology 1.2k
  • Organic Chemistry 745
  • Infectious Diseases 408
  • Epidemiology 325
  • Virology 282
Replace Li Huang with:
Li Huang United States
Chunlin Zhuang China
Alessandra Pani Italy
Giosuè Costa Italy
Yung-Chi Cheng United States
Benoît Déprez France
Jean‐Pierre Falgueyret Canada
Philippe Cotelle France
Alex Buko United States
Giuseppe La Regina Italy
Xiao Ding relative to Li Huang United States Li Huang's profile →
Citations per field
00.5×3.4×
Li Huang · 1×
Citations per year

Countries citing papers authored by Xiao Ding

Since Specialization
Citations

This map shows the geographic impact of Xiao Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Ding more than expected).

Fields of papers citing papers by Xiao Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Ding. The network helps show where Xiao Ding may publish in the future.

Co-authorship network of co-authors of Xiao Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Ding. A scholar is included among the top collaborators of Xiao Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Ding. Xiao Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 20
5 66
6 15
7 22
8 92
9 22
10 46
11 21
12 26
13 12
14 29
15 40
16 28
17 29
18 84
19 59
20 96

About Xiao Ding

Xiao Ding is a scholar working on Virology, Pharmacology and Toxicology, having authored 118 papers that have together received 2.7k indexed citations. Recurring topics across this work include Bioactive Natural Diterpenoids Research (14 papers), HIV/AIDS drug development and treatment (13 papers) and HIV Research and Treatment (11 papers). The work is most often cited by research in Virology (282 citations), Pharmacology (258 citations) and Organic Chemistry (745 citations). Xiao Ding has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Xiao‐Jiang Hao, Xinyong Liu, Hong Liu, Hualiang Jiang, Peng Zhan, Shun‐Lin Li, Yu Zhang, Yueqin Zhao, Yuhan Zhao and Dongwei Kang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026